MDGL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 23.92%

Insider Buying (Last 12 Months): $43,382,043.47

Insider Selling (Last 12 Months): $33,116,646.13

Madrigal Pharmaceuticals Insider Trading History Chart

Madrigal Pharmaceuticals Share Price & Price History

^$194.38

▼ -10.27 (-5.02%)

As of 04/25/2024 06:12 PM ET

Days: 30 | 90 | 365

Jim Cramer’s “The Biggest Drug Ever”

From Behind the Markets | Ad

This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

Madrigal Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/8/2024	Paul A Friedman	Director	Sell	26,270	$246.19	$6,467,411.30	185,735
4/8/2024	Rebecca Taub	CMO	Sell	2,676	$245.99	$658,269.24	458,999
4/5/2024	Rebecca Taub	CMO	Sell	27,506	$243.36	$6,693,860.16	458,999
4/4/2024	Paul A Friedman	Director	Sell	18,710	$242.96	$4,545,781.60	185,735
4/3/2024	Rebecca Taub	CMO	Sell	27,845	$245.14	$6,825,923.30	458,999
4/1/2024	James M Daly	Director	Sell	32,489	$102.77	$3,338,894.53	1,198
4/1/2024	Richard S. Levy	Director	Sell	11,000	$257.48	$2,832,280.00	10,298
12/13/2023	Bros. Advisors Lp Baker	Director	Buy	81,159	$219.39	$17,805,473.01	1,774,294
12/13/2023	Robert E. Waltermire	VP	Sell	2,500	$225.40	$563,500.00	5,667
12/4/2023	Brian Joseph Lynch	SVP	Sell	1,800	$218.87	$393,966.00	15,001
11/29/2023	Brian Joseph Lynch	SVP	Sell	4,000	$199.19	$796,760.00	15,001
11/21/2023	Bros. Advisors Lp Baker	Director	Buy	64,350	$188.47	$12,128,044.50	1,667,104
11/17/2023	Bros. Advisors Lp Baker	Director	Buy	46,370	$174.70	$8,100,839.00	1,588,541
11/14/2023	Bros. Advisors Lp Baker	Director	Buy	34,188	$156.42	$5,347,686.96	1,531,757
1/17/2023	Richard S. Levy	Director	Sell	22,489	$293.15	$6,592,650.35	9,100
1/3/2023	Brian Joseph Lynch	SVP	Sell	13,000	$282.92	$3,677,960.00
12/23/2022	Brian Joseph Lynch	SVP	Sell	7,000	$274.18	$1,919,260.00
12/23/2022	Remy Sukhija	insider	Sell	30,000	$274.14	$8,224,200.00

World’s biggest multibillionaire investor is buying THIS by the ton [picture]

From Stansberry Research | Ad

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

Click here to find out what to do.

SEC Filings (Institutional Ownership Changes) for Madrigal Pharmaceuticals (NASDAQ:MDGL)

98.50% of Madrigal Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Madrigal Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/24/2024	Newbridge Financial Services Group Inc.	11,033	$2.95M	1.3%	N/A	0.055%
4/24/2024	Assenagon Asset Management S.A.	12,958	$3.46M	0.0%	-32.1%	0.065%
4/23/2024	Sweet Financial Partners LLC	1,000	$0.27M	0.1%	N/A	0.005%
4/22/2024	PFG Investments LLC	858	$0.23M	0.0%	N/A	0.004%
4/22/2024	Raymond James & Associates	20,284	$5.42M	0.0%	+2.8%	0.102%
4/22/2024	Investors Asset Management of Georgia Inc. GA ADV	875	$0.23M	0.1%	N/A	0.004%
4/22/2024	Shikiar Asset Management Inc.	5,400	$1.44M	0.4%	+8.0%	0.027%
4/19/2024	AMI Asset Management Corp	9,618	$2.57M	0.1%	+101.5%	0.048%
4/19/2024	Sumitomo Mitsui Trust Holdings Inc.	839	$0.22M	0.0%	-65.1%	0.004%
4/18/2024	Allspring Global Investments Holdings LLC	381	$0.10M	0.0%	N/A	0.002%
4/17/2024	Hennion & Walsh Asset Management Inc.	32,318	$8.63M	0.5%	+20.0%	0.162%
4/16/2024	Congress Park Capital LLC	1,200	$0.32M	0.1%	N/A	0.006%
4/16/2024	Overbrook Management Corp	1,130	$0.30M	0.1%	N/A	0.006%
4/11/2024	Rheos Capital Works Inc.	110,215	$29.43M	1.4%	N/A	0.554%
3/11/2024	Vanguard Group Inc.	1,574,742	$364.36M	0.0%	+0.1%	7.913%
2/26/2024	Virtu Financial LLC	4,063	$0.94M	0.1%	N/A	0.021%
2/26/2024	Perceptive Advisors LLC	151,151	$34.97M	0.8%	+21.3%	0.766%
2/22/2024	Sierra Summit Advisors LLC	1,434	$0.33M	0.1%	N/A	0.007%
2/15/2024	Osterweis Capital Management Inc.	15,147	$3.51M	0.2%	+96.3%	0.077%
2/15/2024	Frazier Life Sciences Management L.P.	69,406	$16.06M	0.9%	N/A	0.352%
2/14/2024	Paulson & CO. Inc.	1,105,741	$255.85M	23.1%	+121.1%	5.602%
2/14/2024	Avoro Capital Advisors LLC	1,888,888	$437.05M	6.1%	+21.5%	9.569%
2/14/2024	RTW Investments LP	815,191	$188.62M	3.0%	+163.4%	4.130%
2/14/2024	Sectoral Asset Management Inc.	1,201	$0.28M	0.1%	-94.3%	0.006%
2/14/2024	CenterBook Partners LP	953	$0.22M	0.0%	-94.7%	0.005%
2/13/2024	Bain Capital Life Sciences Investors LLC	324,619	$75.11M	7.2%	N/A	1.644%
2/13/2024	University of Wisconsin Foundation	73,487	$17M	28.3%	+83.1%	0.372%
2/13/2024	Affinity Asset Advisors LLC	100,000	$23.14M	4.3%	+17.6%	0.507%
2/13/2024	Rafferty Asset Management LLC	43,099	$9.97M	0.0%	-4.9%	0.218%
2/13/2024	Rhenman & Partners Asset Management AB	22,500	$5.21M	0.5%	N/A	0.114%
2/13/2024	NEOS Investment Management LLC	1,892	$0.44M	0.0%	N/A	0.010%
2/12/2024	TD Asset Management Inc	15,540	$3.60M	0.0%	N/A	0.079%
2/12/2024	Artisan Partners Limited Partnership	296,480	$68.60M	0.1%	+5.9%	1.502%
2/12/2024	Hsbc Holdings PLC	16,949	$3.92M	0.0%	+19.0%	0.086%
2/9/2024	Cambridge Investment Research Advisors Inc.	6,157	$1.43M	0.0%	-12.2%	0.031%
2/9/2024	UBS Group AG	88,377	$20.45M	0.0%	+57.3%	0.448%
2/9/2024	Norges Bank	145,589	$33.69M	0.0%	N/A	0.738%
2/7/2024	Principal Financial Group Inc.	3,875	$0.90M	0.0%	+3.8%	0.020%
2/7/2024	Dana Investment Advisors Inc.	3,171	$0.73M	0.0%	+4.1%	0.016%
2/7/2024	BNP Paribas Financial Markets	22,769	$5.27M	0.0%	+37.0%	0.115%
2/7/2024	Teacher Retirement System of Texas	2,474	$0.57M	0.0%	-13.5%	0.013%
2/6/2024	Charles Schwab Investment Management Inc.	120,212	$27.82M	0.0%	+9.8%	0.609%
2/6/2024	First National Trust Co	4,414	$1.02M	0.0%	-9.3%	0.022%
2/6/2024	Amalgamated Bank	2,119	$0.49M	0.0%	+2.8%	0.011%
2/6/2024	Swiss National Bank	21,400	$4.95M	0.0%	-3.2%	0.108%
2/5/2024	Victory Capital Management Inc.	1,920	$0.44M	0.0%	+35.1%	0.010%
2/5/2024	AtonRa Partners	3,433	$0.79M	1.6%	-11.0%	0.017%
2/2/2024	Headlands Technologies LLC	2,045	$0.47M	0.1%	N/A	0.010%
2/2/2024	AlpInvest Partners B.V.	211,488	$48.93M	11.2%	N/A	1.071%
2/2/2024	State of New Jersey Common Pension Fund D	13,106	$3.03M	0.0%	-6.6%	0.066%
2/1/2024	New York State Common Retirement Fund	18,347	$4.25M	0.0%	+10.6%	0.093%
2/1/2024	California Public Employees Retirement System	20,190	$4.67M	0.0%	-18.8%	0.102%
2/1/2024	Handelsbanken Fonder AB	3,300	$0.76M	0.0%	+17.9%	0.017%
1/31/2024	Knights of Columbus Asset Advisors LLC	8,695	$2.01M	0.1%	+101.8%	0.044%
1/31/2024	Xponance Inc.	891	$0.21M	0.0%	N/A	0.005%
1/30/2024	HealthInvest Partners AB	2,531	$0.59M	0.5%	N/A	0.013%
1/30/2024	Strs Ohio	800	$0.19M	0.0%	-52.9%	0.004%
1/30/2024	Sumitomo Mitsui Trust Holdings Inc.	2,405	$0.56M	0.0%	+10.4%	0.012%
1/26/2024	Mutual of America Capital Management LLC	12,803	$2.96M	0.0%	-4.3%	0.065%
1/26/2024	Moody Aldrich Partners LLC	9,223	$2.13M	0.4%	-32.1%	0.047%
1/25/2024	New Harbor Financial Group LLC	911	$0.21M	0.1%	N/A	0.005%
1/25/2024	Nisa Investment Advisors LLC	116	$27K	0.0%	-43.7%	0.001%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	61,508	$14.36M	0.0%	-1.2%	0.312%
1/24/2024	Arizona State Retirement System	3,032	$0.70M	0.0%	+5.8%	0.015%
1/24/2024	China Universal Asset Management Co. Ltd.	2,292	$0.53M	0.1%	+389.7%	0.012%
1/19/2024	AMI Asset Management Corp	4,773	$1.10M	0.1%	N/A	0.024%
1/19/2024	JGP Global Gestao de Recursos Ltda.	1,305	$0.30M	0.3%	N/A	0.007%
1/18/2024	Global Retirement Partners LLC	122	$30K	0.0%	+454.5%	0.001%
1/17/2024	Assenagon Asset Management S.A.	19,082	$4.42M	0.0%	-55.0%	0.097%
1/16/2024	Raymond James & Associates	19,730	$4.57M	0.0%	-3.5%	0.100%
1/12/2024	Everhart Financial Group Inc.	1,143	$0.26M	0.1%	N/A	0.006%
12/18/2023	Vanguard Group Inc.	1,573,338	$229.77M	0.0%	+7.4%	7.970%
11/30/2023	American Century Companies Inc.	63,609	$9.29M	0.0%	+30.0%	0.322%
11/24/2023	Deutsche Bank AG	43,871	$6.41M	0.0%	+18.5%	0.222%
11/22/2023	Verity Asset Management Inc.	2,687	$0.39M	0.3%	+36.7%	0.014%
11/15/2023	Dana Investment Advisors Inc.	3,047	$0.45M	0.0%	N/A	0.015%
11/15/2023	RA Capital Management L.P.	204,500	$29.87M	0.6%	N/A	1.036%
11/15/2023	RTW Investments LP	309,485	$45.20M	1.0%	+39.7%	1.568%
11/15/2023	Rock Springs Capital Management LP	196,369	$28.68M	0.8%	-1.4%	0.995%
11/15/2023	Sectoral Asset Management Inc.	20,901	$3.05M	0.6%	+10.1%	0.106%
11/15/2023	L1 Capital Pty Ltd	48,469	$7.08M	0.6%	+6.0%	0.246%
11/15/2023	Laurion Capital Management LP	16,028	$2.34M	0.0%	N/A	0.081%
11/15/2023	Affinity Asset Advisors LLC	85,000	$12.41M	3.5%	-41.6%	0.431%
11/15/2023	Glenmede Trust Co. NA	1,567	$0.23M	0.0%	+53.2%	0.008%
11/14/2023	MPM Bioimpact LLC	40,859	$5.97M	1.6%	+7.5%	0.207%
11/14/2023	Schonfeld Strategic Advisors LLC	71,535	$10.45M	0.1%	+260.1%	0.362%
11/14/2023	Fred Alger Management LLC	19,864	$2.90M	0.0%	+2.3%	0.101%
11/14/2023	MBB Public Markets I LLC	5,990	$0.88M	0.1%	+9.1%	0.030%
11/14/2023	Tower Research Capital LLC TRC	2,060	$0.30M	0.0%	+21.7%	0.010%
11/14/2023	University of Wisconsin Foundation	40,133	$5.86M	6.7%	N/A	0.203%
11/14/2023	Monashee Investment Management LLC	15,000	$2.19M	0.9%	N/A	0.076%
11/14/2023	Profund Advisors LLC	7,723	$1.13M	0.1%	+32.6%	0.039%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	51,686	$7.55M	0.0%	-21.4%	0.262%
11/13/2023	CenterBook Partners LP	18,027	$2.63M	0.3%	N/A	0.091%
11/13/2023	FMR LLC	440,380	$64.31M	0.0%	+26.2%	2.231%
11/13/2023	Rafferty Asset Management LLC	45,323	$6.62M	0.0%	+45.0%	0.230%
11/13/2023	Maven Securities LTD	3,298	$0.48M	0.0%	N/A	0.017%
11/13/2023	E Fund Management Co. Ltd.	2,327	$0.34M	0.0%	+38.3%	0.012%
11/9/2023	Rhumbline Advisers	19,223	$2.81M	0.0%	+2.0%	0.097%
11/9/2023	Montag A & Associates Inc.	194	$28K	0.0%	+223.3%	0.001%

Data available starting January 2016

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.

Today's Range

Now: $194.38

$190.22

$200.97

50 Day Range

MA: $244.64

$204.65

$283.23

52 Week Range

Now: $194.38

$119.76

$322.67

Volume

707,088 shs

Average Volume

530,471 shs

Market Capitalization

$3.87 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Madrigal Pharmaceuticals?: Madrigal Pharmaceuticals' top insider investors include:
Bros Advisors Lp Baker (Director)
Rebecca Taub (CMO)
Paul A Friedman (Director)
Brian Joseph Lynch (SVP)
Richard S Levy (Director)
Robert E Waltermire (VP)
James M Daly (Director)
Remy Sukhija (Insider)
Learn More about top insider investors at Madrigal Pharmaceuticals.
Who are the major institutional investors of Madrigal Pharmaceuticals?: Madrigal Pharmaceuticals' top institutional shareholders include:
Rheos Capital Works Inc. — 0.55%
Hennion & Walsh Asset Management Inc. — 0.16%
Simplex Trading LLC — 0.00%
Raymond James & Associates — 0.10%
Assenagon Asset Management S.A. — 0.07%
Newbridge Financial Services Group Inc. — 0.06%
Learn More about top institutional investors of Madrigal Pharmaceuticals stock.
Which major investors are selling Madrigal Pharmaceuticals stock?: During the last quarter, MDGL stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Sumitomo Mitsui Trust Holdings Inc.
Within the previous year, company insiders that have sold Madrigal Pharmaceuticals company stock include:
Bros Advisors Lp Baker (Director)
Rebecca Taub (CMO)
Paul A Friedman (Director)
Brian Joseph Lynch (SVP)
Richard S Levy (Director)
Robert E Waltermire (VP)
Learn More investors selling Madrigal Pharmaceuticals stock.
Which major investors are buying Madrigal Pharmaceuticals stock?: Within the last quarter, MDGL stock was purchased by institutional investors including:
Rheos Capital Works Inc.
Simplex Trading LLC
Newbridge Financial Services Group Inc.
Hennion & Walsh Asset Management Inc.
AMI Asset Management Corp
Congress Park Capital LLC
Overbrook Management Corp
Sweet Financial Partners LLC